4
Changes in Ownership
Trevi Therapeutics, Inc. Filed Acc 0001209191-23-009694
Chief Financial Officer sold 8,474 shares at $2.45 ($20,761)
- Chief Financial Officer acquired 27,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Delfini Lisa · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-13 | Exercise or conversion : show line 1 in the form | +27,500 | $0.51 | $14,053 | 31,812 | D |
| 2023-02-13 | Sale : show line 2 in the form | −8,474 | $2.45 | $20,761 | 23,338 | D |
| Open-market sales · 8,474 sh · avg $2.45 · $20,761 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-13 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −27,500 | 82,500 | D |
Loading xslF345X03/doc4.xml…